MAPK3 and non-small cell lung carcinoma: Based on our data, considering that both p-p38 and p-ERK1/2 are two key components of the MAPK pathway, we conclude that EMP2 suppressed tumor cell growth mainly by inhibition of MAPK pathway in NSCLC.